ABI

Adamant Biomedical Investments Portfolio holdings

AUM $418M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$401M
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
96
New
Increased
Reduced
Closed

Top Buys

1 +$19.2M
2 +$18.7M
3 +$18.1M
4
CYTO
Altamira Therapeutics Ltd
CYTO
+$13.4M
5
AMGN icon
Amgen
AMGN
+$13.1M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 86.61%
2 Financials 1.21%
3 Industrials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$184B
$20.9M 5.22%
+196,390
CELG
2
DELISTED
Celgene Corp
CELG
$19.6M 4.89%
+206,720
BIIB icon
3
Biogen
BIIB
$27.9B
$18.2M 4.54%
+55,020
AMGN icon
4
Amgen
AMGN
$204B
$14M 3.51%
+100,000
AGN
5
DELISTED
Allergan plc
AGN
$12.6M 3.14%
+52,110
SLXP
6
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$12.2M 3.05%
+78,210
UNH icon
7
UnitedHealth
UNH
$264B
$11M 2.76%
+128,000
VTRS icon
8
Viatris
VTRS
$16.9B
$10.5M 2.61%
+230,000
CYTO
9
DELISTED
Altamira Therapeutics Ltd
CYTO
$10M 2.5%
+27
ALXN
10
DELISTED
Alexion Pharmaceuticals
ALXN
$9.95M 2.48%
+60,000
MDT icon
11
Medtronic
MDT
$123B
$9.29M 2.32%
+150,000
ABT icon
12
Abbott
ABT
$197B
$8.32M 2.08%
+200,000
VRTX icon
13
Vertex Pharmaceuticals
VRTX
$121B
$8.2M 2.05%
+73,000
MCK icon
14
McKesson
MCK
$120B
$7.98M 1.99%
+41,000
CAH icon
15
Cardinal Health
CAH
$52.5B
$7.87M 1.96%
+105,000
MNK
16
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$7.21M 1.8%
+80,000
ILMN icon
17
Illumina
ILMN
$19.7B
$7.05M 1.76%
+44,204
CNC icon
18
Centene
CNC
$22.1B
$6.49M 1.62%
+313,840
REGN icon
19
Regeneron Pharmaceuticals
REGN
$83.3B
$6.49M 1.62%
+18,000
TEVA icon
20
Teva Pharmaceuticals
TEVA
$38.3B
$6.45M 1.61%
+120,000
AGN
21
DELISTED
Allergan Inc
AGN
$6.24M 1.56%
+35,000
MOH icon
22
Molina Healthcare
MOH
$7.73B
$5.54M 1.38%
+131,050
IONS icon
23
Ionis Pharmaceuticals
IONS
$12.9B
$5.44M 1.36%
+140,000
CTRX
24
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$5.25M 1.31%
+136,740
BIB icon
25
ProShares Ultra NASDAQ Biotechnology
BIB
$89.4M
$5.2M 1.3%
+100,000